Geographic Atrophy

Latest News

Topcon Healthcare acquires RetInSight - © InfiniteFlow—stock.adobe.com
Topcon Healthcare acquires RetInSight to fuel AI in retinal disease diagnosis, monitoring

May 2nd 2025

With the acquisition, Topcon Healthcare also assumes RetInSight’s AI algorithms that analyze retinal images to detect and monitor disease.

Needle being filled from vial Image credit: AdobeStock/Trsakaoe
Eyestem Research's phase 1/2a trial results find significant vision improvements in patients treated with Eyecyte-RPE for GA

April 15th 2025

CRU 2025 graphic
CRU 2025: The latest in treatments for DR, nAMD, and GA

April 9th 2025

Video Series
Video Interviews
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.